期刊文献+

血管内皮生长因子对人骨髓和脐带间充质干细胞中内皮细胞组分的影响 被引量:5

Influence of Vascular Endothelial Growth Factor on Endothelial Components in Human Bone Marrrow and Umbilical Cord Mesenchymal Stem Cells
下载PDF
导出
摘要 本研究旨在比较人骨髓间充质干细胞(BM-MSC)和脐带间充质干细胞(UC-MSC)中的内皮细胞(EC)比例,并探讨血管内皮生长因子(VEGF)对MSC中EC比例的影响。利用流式细胞术检测EC标志CD34+CD133+和vWF+CD31+双阳性细胞的比例,用瑞氏染色观察经VEGF作用的MSC细胞形态变化,免疫荧光技术观察CD34、CD133、CD31、VWF的表达,最后采用实时荧光定量PCR检测VEGF对EC标志性基因表达的影响。结果表明:BM-MSC和UC-MSC中存在少量EC及内皮祖细胞(EPC),经VEGF 10 ng/ml作用24 h后,MSC的长宽比变大,EC比例上升而EPC比例下降,EC相关标志基因Tie-2和ecNOS等的表达均上调,其中UC-MSC对VEGF的反应更明显。结论:BM-MSC和UC-MSC中存在少量的EC及EPC,VEGF可以提高EC的比例和细胞功能。 This study was aimed to compare the proportion of endothelial cells(EC) in human bone mrrrow mesenchymal stem cell(BM-MSC) and human umbilical cord mesenchymal stem cells(UC-MSC),and to investigate the influence of vascular endothelial growth factor(VEGF) on proportion of EC in MSC.Flow cytometry was used to detect the proportion of CD34+CD133+ and vWF+CD31+ double positive cells in MSC.Wright’s staining was employed to observe the influence of VEGF on morphology of MSC.The expressions of CD34,CD133,CD31,vWF were detected by immunofluorescence.qRT-PCR was performed to detect the influence of VEGF on EC marker genes’ expression of MSC.The results showed that there were a small amount of EC and endothelial progenitor cells(EPC) in obtained BM-MSC and UC-MSC.After exposed to VEGF 10 ng/ml for 24 h,aspect ratio of MSC and the propotion of EC increased,while proportion of EPC decreased.Expression of EC related marker genes such as Tie-2 and ecNOS up-regulated,especially in UC-MSC.It is concluded that small amount of EC and EPC exists in cultured BM-MSC and UC-MSC,VEGF can enhance the proportion and function of EC in MSC.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第3期717-721,共5页 Journal of Experimental Hematology
基金 山东省科技攻关计划(编号2009GG10002027) 山东省自然科学基金(编号2006BS03038&2006BS03019)
关键词 脐带间充质干细胞 骨髓间充质干细胞 内皮细胞 内皮祖细胞 血管内皮生长因子 umbilical cord mesenchymal stem cell bone marrow mesenchymal stem cell endothelial cell endothelial progenitor cell vascular endothelial growth factor
  • 相关文献

参考文献18

  • 1Sellheyer K, Krahl D. Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications. Hantarzt, 2010 ;61 (5) :429 -434.
  • 2Senseb6 L, Krampera M, Schrezenmeier H, et al. Mesenchymal stem cells for clinical application. Vox Sang, 2010 ; 98 ( 2 ) : 93 - 107.
  • 3Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002 ; 418(6893) :41 -49.
  • 4Yamamoto K, Kondo T, Suzuki S, et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol, 2004 ; 24 ( 12 ) : e192 - e196.
  • 5Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA, 2005; 102 (32) : 11474 - 11479.
  • 6Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leuk Res, 2007 ; 31 ( 4 ) :439 - 444.
  • 7Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997; 275 (5302) :964 -967.
  • 8Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood- derived endothelial precursor cells augment posmatal neovascu- larization. J Clin Invest, 2000 ; 105 ( 11 ) : 1527 - 1536.
  • 9Peichev M, Nalyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 ( + ) cells identifies a population of functional endothelial precursors. Blood, 2000; 95 (3) :952 -958.
  • 10Makjka, Jackson KA, Kienstra KA, et al. Distinct progenitor populations in skeletal muscleare bone marrowdefivedand exhibit different cell fates during vascular regeneration. J Clin Invest, 2003; 111(1):71 -79.

二级参考文献9

共引文献22

同被引文献38

  • 1袁源,杨树源,韩忠朝,张晓辉.人脐带间充质干细胞体外扩增和向神经元样细胞定向诱导分化的研究[J].中华神经医学杂志,2006,5(3):230-236. 被引量:29
  • 2Senger D R, GaUi S J, Dvorak A M, et al . Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid [J].Science,1983,219 (4587):983-985.
  • 3Houck K A, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA[J]. Mol Endocrinol, 1991,5(12):1806-1814.
  • 4Poltorak Z, Cohen T, Sivan R, et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to ex- tracellular matrix [J]. J Biol Chem, 1997,272 (11):7151- 7158.
  • 5Mei J,Gao Y,Zhang L,et al. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vas-culogenic mimicry in osteosarcoma in vitro[J]. Exp Oncol, 2008,30:29-34.
  • 6Gerber H P, Hillan K J, Ryan A M, et al. VEGF is required forgrowth and urvival in neonatal mice [J]. Development, 1999, 126: 1149-1159.
  • 7Napoleone Ferrara. VEGF-A: a critical regulator of blood vessel growth [J ]. European Cytokine Network,2009,20 (4): 158-163.
  • 8Bihon R L , Booker G W . The subtle side to hypoxia in- ducible factor (HIFalpha)regulation [J].Eur J Biochem, 2003,270(5 ) : 791-798.
  • 9Semenza G L.Hydroxylation of HIF-I: oxygen sensing at the molecular level[J]. Physiology(B ethesda), 2004, 19: 176-182.
  • 10Pugh C W,Patcliffe P J.Regulation of angiogenesis by hy- Poxia:role of the HIF system[J].Nat.Med,2003,9(6):677- 684.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部